Latest News and Press Releases

WALTHAM, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Crescent Biopharma, Inc. (“Crescent” or the “Company”) (Nasdaq: CBIO), a clinical-stage biotechnology company dedicated to rapidly advancing the...

MDNA11, as a single agent or in combination with pembrolizumab, continues to demonstrate compelling anti-tumor activity in patients with advanced or metastatic cutaneous melanoma, endometrial cancer...

AUSTIN, Texas, June 26, 2026 (GLOBE NEWSWIRE) -- via IBN – NetworkNewsAudio announces the Audio Press Release (APR) titled “Next-Generation DNA Repair Therapies Open New Frontiers in Oncology,”...

WOBURN, Mass., June 26, 2026 (GLOBE NEWSWIRE) -- Replimune Group, Inc. (NASDAQ: REPL), a clinical-stage biotechnology company pioneering the development of novel oncolytic immunotherapies, announced...

Austin, TX, USA, June 26, 2026 (GLOBE NEWSWIRE) -- Healthcare Foresights has published a new research report titled “In Silico Clinical Trials Market Size, Trends and Insights By Component...

Part C domestic enrollment is underway at three clinical sites in the U.S. CHICAGO, June 25, 2026 (GLOBE NEWSWIRE) -- MAIA Biotechnology, Inc. (NYSE American: MAIA) (“MAIA”, the “Company”), a...

New York, USA, June 24, 2026 (GLOBE NEWSWIRE) -- Global HPV Vaccines Market to Grow Rapidly at a CAGR of ~8% by 2034 | DelveInsight The HPV vaccines market is witnessing significant growth due to...

NEW YORK, June 24, 2026 (GLOBE NEWSWIRE) -- Silvercrest Asset Management Group LLC (NASDAQ: SAMG) today announced that its Global Value Opportunity Fund has received a ‘Recommended’ rating from...

AUSTIN, Texas, June 24, 2026 (GLOBE NEWSWIRE) -- BioMedWire Editorial Coverage: Oncology research is moving through one of its most active stretches in years. DNA Damage Response (“DDR”) inhibitors,...

OCALA, Fla., June 24, 2026 (GLOBE NEWSWIRE) -- AIM ImmunoTech Inc. (NYSE American: AIM) (“AIM” or the “Company”) today highlighted the significant progress achieved across its pancreatic cancer...